Advertisement
The Lancet Microbe Home

About The Lancet Microbe

About the journal

The Lancet Microbe publishes research on clinically relevant microbes at all scales—from the nature of the microbe (eg, antimicrobial resistance genes/plasmids, virulence factors) to the microbiome, to pathology (including immunology) to population level effects (eg, outbreaks, epidemiology). Furthermore, it includes early phase clinical trials and other interventional studies where the outcomes are focused on the pathogen. The Lancet Microbe provides a destination for the best microbiology-focused clinical research. This research is handled in the rigorous manner expected of any journal within the Lancet family. Also in keeping with the Lancet ethos, The Lancet Microbe is a strong advocate for and collaborator with the microbial research community.

The journal is indexed in the Directory of Open Access journals (DOAJ).

Information for Authors

In keeping with other Lancet journals, The Lancet Microbe offers rapid publication of research online within 8–12 weeks from submission. Wherever possible, figures and good quality photographs should be used to supplement and to enhance the text. We also welcome videos. All original research is subjected to the Lancet family of journals’ usual rigorous standards of external clinical and statistical peer review, and edited by experienced technical copy editors to the highest standards.

Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. The Lancet journals are signatories of the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations), and to the Committee on Publication Ethics (COPE) code of conduct for editors. We follow COPE's guidelines.

We also welcome pre-submission enquiries. To find out more please contact: [email protected]

Article processing charges

No subscription or pay-per-view charges apply to any content published in The Lancet Microbe. In order to cover the costs of reviewing, copy editing, layout, and online hosting and archiving, the journal charges an article processing fee of $5000 upon acceptance of submitted research articles (no fee applies to Comment or Correspondence).

Authors whose main funder is located either in group A or B countries of the Health Inter Network Access to Research Initiative (HINARI) or in a country with a low UNDP human development index will be exempt from payment. For authors with no formal funding, the country of origin of the majority of authors' institutions will be taken as the source country. If there is no majority country, the corresponding author's country will be so designated.

The editorial decision to accept is taken well before any request is made as to the ability to pay. Payments are processed by a department unconnected to The Lancet Microbe's editorial department.

Copyright and reuse

All content is published under Creative Commons licensing, which enables authors to retain copyright while allowing others to copy, distribute, and make some uses of their work, provided full credit is given to them as originators. Authors will be offered a choice of two licences (CC BY or CC BY-NC-ND) depending on whether or not they wish to allow commercial reuse of their work and whether or not they wish to allow others to alter their work in the course of its reuse. Authors will be asked to sign a licence to permit our publisher, Elsevier, to publish the work in The Lancet Microbe.

Publishing excellence

As trusted sources of information, the Lancet journals set extremely high standards for publishing, and we are committed to ensuring that our editorial processes meet our standards of excellence. From acceptance of your paper through to publication and beyond, our in-house teams of professional Editors, Assistant Editor, Illustrators, Production Editors, and Marketing and Communications experts can provide personal attention and guidance to strengthen the accuracy, accessibility, timeliness, and impact of your research.

About the Editorial team

Onisillos Sekkides, Editor-in-Chief
Onisillos Sekkides is the founding Editor-in-Chief of The Lancet Microbe. His studies began in 1994 as a biology undergraduate at what is now Queen Mary, University of London. He then went on to study biochemical engineering at University College London and subsequently medical microbiology at London School of Hygiene & Tropical Medicine. Onisillos joined the Lancet journals’ editorial team as an Assistant Editor in 2009 and after several roles across the journals he became Deputy Editor of The Lancet Infectious Diseases from 2014 to 2019. In 2020, he became the inaugural Editor of The Lancet Microbe.

Elena Dalla Vecchia, Senior Editor
Elena Dalla Vecchia is a Senior Editor at The Lancet Microbe. Having acquired a BSc and MSc in Environmental Engineering from Politecnico di Torino (Turin, Italy), in 2009 she undertook a PhD in Environmental Microbiology at EPFL (Lausanne, Switzerland), which she completed in 2014. She then worked as Editorial Assistant and Journal Operations Specialist at Frontiers, as a technical translator at Politecnico di Torino, and as a freelance science editor. Elena joined The Lancet as a Senior Assistant Editor in 2018, and in 2020 became Senior Editor at The Lancet Microbe.

International Advisory Board

The Lancet Microbe's International Advisory Board members.

Ombudsman

Our ombudsman can: investigate delays in handling submitted manuscripts; discourtesy; failure to follow outlined procedures; failure to take reasonable account of representations to us by authors and readers; and challenges to the publishing ethics of the journal. If you have concerns about any of the above, please first contact an editor or the editorial inbox [email protected]; an editor will then respond to you (often, an editor can respond satisfactorily). If you remain dissatisfied with our response, please contact Malcolm Molyneux ([email protected])

Read more about the ombudsman and see our ombudsman's reports.

The Lancet Group’s Diversity Pledge and No All-Male Panel Policy

Read the Diversity Pledge and No All-Male Panel Policy

October 2020
Volume 1, Issue 6